Cargando…
PPAR-γ Modulators as Current and Potential Cancer Treatments
Worldwide, cancer has become one of the leading causes of mortality. Peroxisome Proliferator-Activated Receptors (PPARs) is a family of critical sensors of lipids as well as regulators of diverse metabolic pathways. They are also equipped with the capability to promote eNOS activation, regulate immu...
Autores principales: | Chi, Tiange, Wang, Mina, Wang, Xu, Yang, Ke, Xie, Feiyu, Liao, Zehuan, Wei, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495261/ https://www.ncbi.nlm.nih.gov/pubmed/34631571 http://dx.doi.org/10.3389/fonc.2021.737776 |
Ejemplares similares
-
PPAR-α Modulators as Current and Potential Cancer Treatments
por: Tan, Yan, et al.
Publicado: (2021) -
Non-Coding RNA as Biomarkers for Type 2 Diabetes Development and Clinical Management
por: Chi, Tiange, et al.
Publicado: (2021) -
Biological Rationale for the Use of PPARγ Agonists in Glioblastoma
por: Ellis, Hayley Patricia, et al.
Publicado: (2014) -
PPARγ and PPARδ as Modulators of Neoplasia and Cell Fate
por: Glazer, Robert I., et al.
Publicado: (2008) -
Diagnostic and Prognostic Value of Circulating CircRNAs in Cancer
por: Wang, Mina, et al.
Publicado: (2021)